1. Home
  2. ALAR vs SCLX Comparison

ALAR vs SCLX Comparison

Compare ALAR & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alarum Technologies Ltd.

ALAR

Alarum Technologies Ltd.

HOLD

Current Price

$7.88

Market Cap

43.7M

Sector

Technology

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$6.48

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALAR
SCLX
Founded
2013
2011
Country
Israel
United States
Employees
N/A
34
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
43.7M
48.5M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
ALAR
SCLX
Price
$7.88
$6.48
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$14.00
N/A
AVG Volume (30 Days)
33.3K
92.4K
Earning Date
05-28-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$24.51
$122.52
Revenue Next Year
$33.43
$186.30
P/E Ratio
$44.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.50
$4.09
52 Week High
$18.00
$34.27

Technical Indicators

Market Signals
Indicator
ALAR
SCLX
Relative Strength Index (RSI) 58.17 39.05
Support Level $7.27 $6.20
Resistance Level $7.69 $8.18
Average True Range (ATR) 0.60 1.38
MACD 0.02 -0.32
Stochastic Oscillator 59.90 1.16

Price Performance

Historical Comparison
ALAR
SCLX

About ALAR Alarum Technologies Ltd.

Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: